CCR6 is required for IL-23–induced psoriasis-like inflammation in mice-Reference-Cited by-同舟云学术

CCR6 is required for IL-23–induced psoriasis-like inflammation in mice

Published:2009-08-03 Issue:8 Volume:119 Page:2317-2329
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Hedrick Michael N.,Lonsdorf Anke S.,Shirakawa Aiko-Konno,Lee Chyi-Chia Richard,Liao Fang,Singh Satya P.,Zhang Hongwei H.,Grinberg Alexander,Love Paul E.,Hwang Sam T.,Farber Joshua M.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference86 articles.

1. Psoriasis

2. Pathogenesis and therapy of psoriasis

3. Getting under the skin: the immunogenetics of psoriasis

4. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

5. A Randomized Trial of Etanercept as Monotherapy for Psoriasis

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasis;Bioactive Materials;2024-11

2. Identifying key inflammatory genes in psoriasis via weighted gene co-expression network analysis: Potential targets for therapy;Biomolecules and Biomedicine;2024-09-06

3. Structural basis for CCR6 modulation by allosteric antagonists;Nature Communications;2024-08-31

4. Targeting IL-1 controls refractory pityriasis rubra pilaris;Science Advances;2024-07-05

5. CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models;Immunopharmacology and Immunotoxicology;2024-07-03